|
It was reported that during a hrpci (high risk percutaneous coronary intervention) procedure, on (b)(6) 2018, an introducer cracked after insertion.The issue was identified during the procedure as follows: upon removal of the dilator, bleeding was noted from around the sheath.After removing the sheath, a crack in the 14f 13cm introducer was found.Amount of blood loss is unknown at this time.Patient is reported to be stable, no extended hospitalization was required.The devices are not available to return as they were discarded.Although requested, additional information has not been received as of date of this report.
|
|
A review of device history record (dhr) was conducted and there were no manufacturing rejects or anomalies recorded in the dhr affecting released product.The released device passed all in-process and qa final inspection steps before shipping to the customer.A complaint review of the reported lot found no additional reports involving this lot number.Per the adelante s2s introducer sheath in-process and final inspection procedure, it states the following regarding visual inspection: with naked eye at a distance of 12" to 18", verify the assembled sheath matches the drawing.Ensure parts are free of kinks, cracks, splits, sinks, excessive flash, loose/embedded foreign material or any other damages.In the instructions for use (ifu) it indicates: never advance or withdraw guidewire or sheath when resistance is met.Determine cause by fluoroscopy and take remedial action.When injecting or aspirating through the sheath, use the sideport only.Dilators, catheters and pacing leads should be removed slowly from the sheath.Rapid removal may damage the valve membrane resulting in blood flow through the valve.The device was in use for treatment.The device was not returned for analysis, therefore, the clinical observation could not be confirmed.Based on the investigation, a capa is not required as findings did not identify a design, labeling or manufacturing non-conformity.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.
|